Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2017 8
Important citations

Wang xi, lu x, yin cc, zhao l, bueso-ramos ce, et al .(2016) myeloid neoplasms associated with t (3; 12)(q26. 2; p13) are clinically aggressive and frequently harbor flt3 mutations: a report of 8 cases and review of literature. journal of leukemia.

Hein dw, la creis rk (2016)design and success of a 21st century cancer education program at the university of louisville. journal of cancer education.1-1.

Guss zd, terezakis sa. substance or style? evaluating advanced radiation therapy delivery techniques for hodgkin lymphoma

Guss zd, terezakis sa. substance or style? evaluating advanced radiation therapy delivery techniques for hodgkin lymphoma.

Besson n, pernin v, zefkili s, kirova ym (2016) evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3d conformal radiotherapy (3dcrt) to intensity-modulated rt (imrt) using helical tomotherapy (ht): a single-centre experience and review of the literature. the british journal of radiology. 89:20150409.

Pravallika s. research & reviews: journal of medical and health sciences.

Khalaf fl(2014)impact of microrna in different diseases and cancer. int. j. gen. can. 1:8-11.

Caivano a, la rocca f, simeon v, girasole m, dinarelli s, et al. (2016) microrna-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies-a short report. cellular oncology.19:1-7.

Wu c, liu q, liu b (2015) microrna-155 hallmarks promising accuracy for the diagnosis of various carcinomas: results from a meta-analysis. disease markers.

Tamayo rr, perez js, jimenez-moleon jj, chacon mj (2014) obesity and multiple myeloma: what do the data tell us?. journal of leukemia.

Yoshida m (2014) mystery of human t-cell leukemia virus type 1: commentary on two viral genes, tax and hbz. j leuk.2:137.

Bar m (2014)adoptive immunotherapy for acute myeloid leukemia: from allogeneic hematopoietic cell transplantation to car t cells. journal of leukemia.

Batty n. how to calculate better our financial risk in oncology?.

Indrasworo d, harto hw (2015)tuli sensorineural pada penderita leukemia mielositik kronik. oto rhino laryngologica indonesiana. 45:160-165.

Thomson is. mohamed ezzat abd el-hack, mahmoud alagawany, mayada ragab farag, ruchi tiwari, et al. (2016) international journal of pharmacology.12:232-48.

Ahmed jh. species differences in methotrexate-induced hepatotoxicity and nephrotoxicity: rabbits resist methotrexate nephrotoxicity.

Gholamnezhad z, havakhah s, boskabady mh (2016) preclinical and clinical effects of nigella sativa and its constituent, thymoquinone: a review. journal of ethnopharmacology.190:372-86.

Mollazadeh h, hosseinzadeh h (2014) the protective effect of nigella sativa against liver injury: a review. iranian journal of basic medical sciences.17:958.

Hosseini a, ghorbani a (2015) cancer therapy with phytochemicals: evidence from clinical studies. avicenna journal of phytomedicine. 5:84.

صفار, رهگذر, شاهی, بیگلریان. تحلیل بقای بیماران مبتلا به سرطان خون حاد میلوئید. مجله علوم پزشکی رازی. 2015 aug 15;22(134):41-8.‎

Relevant Topics